Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial (vol 23, pg 117, 2023)

被引：0
|
作者：
Wedemeyer, H.
Schoneweis, K.
Bogomolov, P.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2022年 / 22卷 / 12期
关键词：
D O I：
10.1016/S1473-3099(22)00657-0
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E348 / E348
页数：1
相关论文
共 39 条
  • [1] Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202) : a multicentre, randomised, parallel-group, open-label, phase 2 trial
    Wedemeyer, Heiner
    Schoeneweis, Katrin
    Bogomolov, Pavel
    Blank, Antje
    Voronkova, Natalia
    Stepanova, Tatiana
    Sagalova, Olga
    Chulanov, Vladimir
    Osipenko, Marina
    Morozov, Viacheslav
    Geyvandova, Natalia
    Sleptsova, Snezhana
    Bakulin, Igor G.
    Khaertynova, Ilsiyar
    Rusanova, Marina
    Pathil, Anita
    Merle, Uta
    Bremer, Birgit
    Allweiss, Lena
    Lempp, Florian A.
    Port, Kerstin
    Haag, Mathias
    Schwab, Matthias
    Wiesch, Julian Schulze zur
    Cornberg, Markus
    Haefeli, Walter E.
    Dandri, Maura
    Alexandrov, Alexander
    Urban, Stephan
    LANCET INFECTIOUS DISEASES, 2023, 23 (01): : 117 - 129
  • [2] Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed chronic hepatitis B patients with hepatic impairment: final 2 year efficacy and safety results from a phase 2, open-label study
    Lim, Young-Suk
    Lin, Chun-yen
    Heo, Jeong
    Bae, Ho
    Chuang, Wan-Long
    Tsang, Tak Yin Owen
    Fournier, Claire
    Hui, Aric Josun
    Huy Trinh
    Tan, Susanna
    Zhao, Yang
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Brainard, Diana
    Ryder, Stephen
    Janssen, Harry L. A.
    JOURNAL OF HEPATOLOGY, 2021, 75 : S755 - S756
  • [3] Safety and efficacy of REP 2139 and pegylated interferon alfa-2α for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial (vol 2, pg 877, 2017)
    Bazinet, M.
    Pantea, V
    Cebotarescu, V
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (01): : E1 - E1
  • [4] EFFICACY AND SAFETY OF BULEVIRTIDE IN COMBINATION WITH PEGYLATED INTERFERON ALFA-2a IN PATIENTS WITH CHRONIC HEPATITIS DELTA: PRIMARY ENDPOINT RESULTS FROM A PHASE 2b OPEN-LABEL, RANDOMIZED, MULTICENTER STUDY MYR204
    Asselah, Tarik
    Lampertico, Pietro
    Wedemeyer, Heiner
    Streinu-Cercel, Adrian
    Pantea, Victor
    Lazar, Stefan
    Placinta, Gheorghe
    Gherlan, George Sebastian
    Bogomolov, Pavel
    Stepanova, Tatiana
    Morozov, Viacheslav
    Chulanov, Vladimir
    Syutkin, Vladimir E.
    Sagalova, Olga
    Gorodin, Vladmir
    Manuilov, Dmitry
    Mercier, Renee-Claude
    Ye, Lei
    Flaherty, John F.
    Osinusi, Anu O.
    Lau, Audrey H.
    Da, Ben L.
    Bourliere, Marc
    Ratziu, Vlad
    Pol, Stanislas
    Hilleret, Marie-Noelle
    Zoulim, Fabien
    HEPATOLOGY, 2024, 79 (02) : E43 - E44
  • [5] Efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: Primary endpoint results from the phase 2b, open-label, randomized, multicenter study MYR204
    Asselah, Tarik
    Lampertico, Pietro
    Wedemeyer, Heiner
    Streinu-Cercel, Adrian
    Pantea, Victor
    Lazar, Stefan
    Placinta, Gheorghe
    Gherlan, George Sebastian
    Bogomolov, Pavel
    Stepanova, Tatyana
    Morozov, Viacheslav
    Chulanov, Vladimir
    Syutkin, Vladimir
    Sagalova, Olga
    Gorodin, Vladimir
    Manuilov, Dmitry
    Mercier, Renee-Claude
    Ye, Lei
    Flaherty, John F.
    Freismuth, Aurelie
    Osinusi, Anu
    Lau, Audrey
    Da, Ben
    Bourliere, Marc
    Ratziu, Vlad
    Pol, Stanislas
    Hilleret, Marie-Noelle
    Zoulim, Fabien
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 104 - 105
  • [6] Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial (vol 1, pg 196, 2016)
    Buti, M.
    Gane, E.
    Seto, W. K.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03): : E2 - E2
  • [7] Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (vol 16, pg 685, 2016)
    Manns, M.
    Samuel, D.
    Gane, E. J.
    LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 636 - 636
  • [8] Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
    Manns, Michael
    Samuel, Didier
    Gane, Edward J.
    Mutimer, David
    McCaughan, Geoff
    Buti, Maria
    Prieto, Martin
    Luis Calleja, Jose
    Peck-Radosavljevic, Markus
    Mullhaupt, Beat
    Agarwal, Kosh
    Angus, Peter
    Yoshida, Eric M.
    Colombo, Massimo
    Rizzetto, Mario
    Dvory-Sobol, Hadas
    Denning, Jill
    Arterburn, Sarah
    Pang, Phillip S.
    Brainard, Diana
    McHutchison, John G.
    Dufour, Jean-Francois
    Van Vlierberghe, Hans
    van Hoek, Bart
    Forns, Xavier
    LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 685 - 697
  • [9] Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial (vol 21, pg 823, 2021)
    Hsu, Y-C
    Chen, C-Y
    Chang, I-W
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : E122 - E122
  • [10] A 24-Week, Parallel-Group, Open-Label, Randomized Clinical Trial Comparing the Early Antiviral Efficacy of Telbivudine and Entecavir in the Treatment of Hepatitis B e Antigen-Positive Chronic Hepatitis B Virus Infection in Adult Chinese Patients
    Zheng, Ming-Hua
    Shi, Ke-Qing
    Dai, Zhi-Juan
    Ye, Chao
    Chen, Yong-Ping
    CLINICAL THERAPEUTICS, 2010, 32 (04) : 649 - 658
1234